Status:

COMPLETED

A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).

Lead Sponsor:

Prokidney

Collaborating Sponsors:

CTI Clinical Trial and Consulting Services

Conditions:

Chronic Kidney Disease

Congenital Anomalies of Kidney and Urinary Tract

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

A phase 1, open-label safety, tolerability and early efficacy study of a Renal Autologous Cell Therapy (REACT) in patients with Chronic Kidney Disease from Congenital Anomalies of the Kidney and Urina...

Detailed Description

It is anticipated that all subjects will receive two planned Renal Autologous Cell Therapy (REACT) injections to allow dose-finding and evaluate the duration of effects. The scientific rationale, base...

Eligibility Criteria

Inclusion

  • The patient is male or female, 18 to 65 years of age on the date of informed consent.
  • The patient has a documented history of a corrected abnormality of the kidney and/or urinary tract (CAKUT) leading to renal dysfunction.
  • The patient has an established diagnosis of Stage III/IV CKD not requiring renal dialysis.
  • The subject has blood pressure less than 150/90 at the Screening Visit, prior to renal biopsy, and prior to REACT injection(s).

Exclusion

  • The patient has a history of renal transplantation.
  • The patient has a diagnosis of hydronephrosis, SFU Grade 4 or 5.
  • The patient has an uncorrected VUR Grade 5.
  • The patient has a diffuse cortical thickness throughout the kidney measuring \< 5 mm on MRI that prevents safe cortical biopsy.

Key Trial Info

Start Date :

August 13 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 31 2023

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT04115345

Start Date

August 13 2019

End Date

January 31 2023

Last Update

December 21 2023

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Emory University Hospital

Atlanta, Georgia, United States, 30322

2

Boise Kidney & Hypertension Institute

Meridian, Idaho, United States, 83642

3

Hackensack Meridian Jersey Shore University Medical Center

Neptune City, New Jersey, United States, 07753

4

Mt. Sinai Hospital

New York, New York, United States, 45246